Regeneron Pharmaceuticals’s 2seventy bio TSVT Stock Holding History

Regeneron Pharmaceuticals’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,254,827	Closed	-$6.2M	–	6
2025 Q1	$6.2M	Hold	1,254,827	–	–	0.5%	3
2024 Q4	$3.69M	Buy	+1,254,827	New	+$5.15M	0.34%	3

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Regeneron Pharmaceuticals's TSVT Position: Q2 2025 in Review

Regeneron Pharmaceuticals sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,254,827 shares — an estimated $6.2M sold.

Regeneron Pharmaceuticals first reported a position in TSVT in Q4 2024 and held it in 2 quarters. The position peaked at $6.2M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Regeneron Pharmaceuticals reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Regeneron Pharmaceuticals sold 1,254,827 2seventy bio shares in Q2 2025, an estimated $6.2M.
Regeneron Pharmaceuticals first reported a position in 2seventy bio in Q4 2024 and held it in 2 quarters.
Regeneron Pharmaceuticals's 2seventy bio position peaked at $6.2M in Q1 2025.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Regeneron Pharmaceuticals's 13F filing for Q2 2025, filed 1 Aug 2025.